Results 101 to 110 of about 3,957 (191)

Metastasis immune-based scores predict patient survival

OncoImmunology, 2020
Treatment of metastatic colorectal cancer is based upon the assumption that metastases are homogeneous within a patient. A comprehensive analysis of all metastases of each patient revealed the heterogeneity of the colorectal metastatic disease and its ...
Bernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde, Jérôme Galon   +3 more
doaj   +1 more source

EBV-associated gastric carcinoma: four-gene immunoscore

Title: EBV-associated gastric carcinoma: four-gene immunoscore — gene expression data, immunoscore coefficients, and clinical data for EBVaGC and EBVnGC samples.
Huo, Ruizhen
core   +1 more source

DataSheet_1_Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology.docx

, 2022
BackgroundInfiltrating immune cells have been reported as prognostic markers in many cancer types. We aimed to evaluate the prognostic role of tumor-infiltrating lymphocytes, namely CD3+ T cells, CD8+ cytotoxic T cells and memory T cells (CD45RO+), in ...
Liang-Jun Qin (12523744), Shuo-Yu Xu (7863191), Ran Wang (169166), Le Li (356426), Lei Miao (528184), Sha Fu (445944), Feng-Hua Wang (1762480), Xiao-Yun Liu (11899710), Shu-Hua Li (691392), Fang Wang (105926), Na Liu (102929), Liang Zeng (791005), Hai-Yun Wang (223336), Kai Chen (129938), Ling Deng (713393)   +14 more
core   +1 more source

Immunoscore for (colorectal) cancer precision medicine [PDF]

The Lancet, 2018
Shuji, Ogino, Marios, Giannakis
openaire   +2 more sources

Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients.

, 2020
Background: Risk assessment is particularly important to decide when to propose an adjuvant treatment for Stage II Colon Cancer (CC) patients. However, the current tumor risk features are imperfect and additional risk factors are needed to guide ...
Hermitte, Fabienne, Meeting Abstract | 2020 ASCO Annual Meeting I - GASTROINTESTINAL CANCER—COLORECTAL AND ANAL, Pages, Franck, Patel, Prabhudas S, Fox, Bernard A, Zavadova, Eva, Roehrl, Michael H.A., Wang, Yili, Lugli, Alessandro, Bifulco, Carlo Bruno, Torigoe, Toshihiko, Ascierto, Paolo Antonio, Galon, Jerome, Mlecnik, Bernhard, Roehrl, Michael H. A., Hartmann, Arndt, Marliot, Florence, Patel, Prabhudas S., Fox, Bernard A., Nagtegaal, Iris D, Nagtegaal, Iris D., Kawakami, Yutaka, Marincola, Francesco, Bifulco, Carlo, Van den Eynde, Marc, Ohashi, Pamela S   +25 more
core   +1 more source

CD3+ and CD8+ T cell-based immune cell score as a prognostic factor in clear-cell renal cell carcinoma

Acta Oncologica
Background and purpose: Immunoscore® is a prognostic parameter based on densities of lymphocyte populations in the tumor center and invasive margin. Immunoscore® is validated in colorectal cancer as a high Immunoscore® is associated with longer survival.
Jonne Åkerla, Olli Helminen, Juha P. Väyrynen, Anne Parkkinen, Hilma Järvenpää, Jan Böhm, Maarit Ahtiainen, Heikki Seikkula   +7 more
doaj   +1 more source

Supplementary Materials and Methods from Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy

, 2016
Custom software for the calculation of the peripheral immunoscore.
Christopher R. Heery (4891468), James L. Gulley (9219173), Janet C. Siebert (10171697), Benedetto Farsaci (14992169), Renee N. Donahue (9219155), Lauren M. Lepone (15002745), Italia Grenga (3771097), Peter S. Kim (6873146), Brendan Dempsey (15113998), Nuhad K. Ibrahim (14983475), Ravi A. Madan (9219176), Jeffrey Schlom (3771100)   +11 more
core   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Quantifying Immunoscore performance – Authors' reply [PDF]

The Lancet, 2018
Franck, Pagès, Bernhard, Mlecnik, Jérôme, Galon   +2 more
openaire   +2 more sources

Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer

Journal of the Egyptian National Cancer Institute
Background Tumor-infiltrating lymphocytes (TILs) and the derived immunoscore (IS) have gained considerable attention over the last decade as prognostic markers in many solid cancers.
Sarra Ben Rejeb, Sirine Elfekih, Nadia Kouki, Rami Boulma, Hassen Khouni   +4 more
doaj   +1 more source